Skye Bioscience
0 followers
‌
Skye Bioscience (OTC: SKYE) is a biopharmaceutical company engineering proprietary cannabinoid derivatives to treat glaucoma and other diseases with significant unmet medical needs.
Industries
Headquarters
Employees
Links
Org chart
Punit Dhillon
Collapse
Kaitlyn Arsenault
Chief Financial Officer
Tu Diep
Chief Development Officer
Chris Twitty
Chief Scientific Officer
Karam Takhar
VP, Corporate Development & Investor Relations
